| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 01/28/1999 | WO1999003884A2 Modified immunogenic pneumolysin, compositions and their use as vaccines |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003881A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 01/28/1999 | WO1999003872A1 Nucleic acid ladders |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1999003507A1 Telomere mimetic compounds and methods of use for same |
| 01/28/1999 | WO1999003506A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 01/28/1999 | WO1999003502A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 01/28/1999 | WO1999003496A1 Factor ix antihemophilic factor with increased clotting activity |
| 01/28/1999 | WO1999003494A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase |
| 01/28/1999 | WO1999003336A1 Transgenic mammals |
| 01/28/1999 | WO1999003328A1 TOXIN GENES FROM THE BACTERIA XENORHABDUS NEMATOPHILUS AND $i(PHOTORHABDUS LUMINESCENS) |
| 01/28/1999 | WO1999003327A1 Method of genetically transforming banana plants |
| 01/28/1999 | WO1999003326A1 Pollen-based transformation system using solid media |
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 01/28/1999 | WO1998048047A3 Characterising dna |
| 01/28/1999 | WO1998048045A3 Method for non-invasive identification of malignant lung tumors |
| 01/28/1999 | WO1998048041A3 Dna probes, method and kit for identifying antibiotic-resistant strains of bacteria |
| 01/28/1999 | WO1998046788A3 Primers and methods for the detection of disseminated tumor cells |
| 01/28/1999 | WO1998046759A3 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 01/28/1999 | WO1998046729A3 Enzyme assay for mutant firefly luciferase |
| 01/28/1999 | WO1998046636A3 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 01/28/1999 | WO1998045477A3 Methods for assessing cardiovascular status and compositions for use thereof |
| 01/28/1999 | WO1998038324A3 Chimeric cell-surface receptors that undergo antigen-induced association |
| 01/28/1999 | WO1998037200A3 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/28/1999 | WO1998027932A3 Cerebellum and embryo specific protein |
| 01/28/1999 | DE19731990A1 Verfahren zur Herstellung und Identifizierung von neuen Hydrolasen mit verbesserten Eigenschaften Process for the preparation and identification of new hydrolases with improved properties |
| 01/28/1999 | DE19731670A1 Purification of nucleic acid by treatment with anion-exchange resin |
| 01/28/1999 | DE19731292A1 Nucleinsäuremolekül, Kit und Verwendung Nucleic acid molecule kit and use |
| 01/28/1999 | DE19731274A1 Verfahren zur Herstellung von Biotin A process for the production of biotin |
| 01/28/1999 | CA2297374A1 Modified immunogenic pneumolysin, compositions and their use as vaccines |
| 01/28/1999 | CA2297105A1 Transgenic mammals |
| 01/28/1999 | CA2297103A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | CA2296840A1 Dna sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants |
| 01/28/1999 | CA2296815A1 64 human secreted proteins |
| 01/28/1999 | CA2296811A1 Improved promoters for enhancing plant productivity |
| 01/28/1999 | CA2296796A1 Special virus dna fragments and their use as promoter |
| 01/28/1999 | CA2296770A1 Derivatives of growth hormone and related proteins |
| 01/28/1999 | CA2296762A1 Interleukin-20 |
| 01/28/1999 | CA2296761A1 Process of producing transgenic plants in which flowering is inhibited, and dna sequences used in said process |
| 01/28/1999 | CA2296738A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | CA2296728A1 Method to produce novel polyketides |
| 01/28/1999 | CA2296708A1 Proteases from gram-positive organisms |
| 01/28/1999 | CA2296689A1 Increasing production of proteins in gram-positive microorganisms |
| 01/28/1999 | CA2296666A1 T-cell receptor beta-like protein |
| 01/28/1999 | CA2296530A1 Adipocyte-specific protein homologs |
| 01/28/1999 | CA2296508A1 Structure of the ankyrin binding domain of a alpha-na,k-atpase |
| 01/28/1999 | CA2296447A1 Human atp-binding cassette transport protein |
| 01/28/1999 | CA2296445A1 Induction of male sterility in plants by expression of high levels of avidin |
| 01/28/1999 | CA2296442A1 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | CA2296419A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 01/28/1999 | CA2296416A1 Assays therapeutic methods and means |
| 01/28/1999 | CA2296393A1 Improved vanillin production |
| 01/28/1999 | CA2296392A1 Use of a virus dna as promoter |
| 01/28/1999 | CA2296378A1 Method of genetically transforming banana plants |
| 01/28/1999 | CA2296366A1 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 01/28/1999 | CA2296319A1 Lentiviral vectors |
| 01/28/1999 | CA2296291A1 Production of pathogen resistant plants |
| 01/28/1999 | CA2296089A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2295719A1 Trail receptor |
| 01/28/1999 | CA2295552A1 Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 01/28/1999 | CA2293737A1 Transformed yeast strains and their use for the production of monoterminal and diterminal aliphatic carboxylates |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/27/1999 | EP0893506A1 Polypeptide of human-origin hyaluronate synthetase and dna encoding the same |
| 01/27/1999 | EP0893505A2 Novel glucose kinase |
| 01/27/1999 | EP0893504A1 Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893502A2 GreA from Staphylococcus aureus |
| 01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
| 01/27/1999 | EP0893500A2 BmrU gene from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892857A1 Analysis of dna |
| 01/27/1999 | EP0892854A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/27/1999 | EP0892851A1 Regulatable retrovirus system for genetic modification of cells |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892813A1 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892808A1 Detection probes, kits and assays |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | EP0804066A4 Transgenic plants with altered senescence characteristics |
| 01/27/1999 | EP0778777A4 A method of sequencing proteins by epitope ordering and protein restriction mapping |
| 01/27/1999 | EP0777727A4 Purified herpes simplex virus protease and methods of purification |
| 01/27/1999 | EP0777675B1 Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides |
| 01/27/1999 | EP0686191A4 Controlled modification of eukaryotic genomes |
| 01/27/1999 | EP0658198B1 Multicistronic expression units and their use |
| 01/27/1999 | EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/27/1999 | EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |